Genex Pharmaceutical, Inc.

Genex Pharmaceutical, Inc. (Genex Pharmaceutical) is a biomedical technology company with distinctive proprietary technology for an orthopedic device that treats bone-related injuries. The company manufactures and distributes Reconstituted Bone Xenograft(RBX) to 500 hospitals in 22 provinces throughout mainland China. RBX is a revolutionary product developed for the treatment of several bone-related injuries. RBX is suitable for compound or complex bone fractures, compression fractures and intractable fractures, bone defects, vertebral column or joint rehabilitation and for bone absence after tumor removal such as a bone cyst. RBX offers a modern alternative to traditional methods of treating orthopedic injuries. The company has obtained various approval for Reconstituted Bone Xenograft from the State Food and Drug Administration(SFDA) in China. Genex Pharmaceutical is headquartered at Tianjin, China.

Street: 
1801 Guangyin Building
City: 
Hexi District
Postcode: 
300074
Federal State : 
China
WebSite: 
www.genexpharm.com
Fax: 
86-22-23379585

Company Index Score

Current Index Score Historical Index Score
  • Genex Pharmaceutical, Inc. currently scores 50 % in the index.
  • Genex Pharmaceutical, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Genex Pharmaceutical, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets